Epstein Index›Documents›EFTA00810552
💨IMPACT LEVEL 1 — MEH

Epstein File EFTA00810552: Large_file_1mb_plus, Intelligence and Submission (DS9)

General DocumentDate unavailableEFTA008105522 keyword hits
1
views
0
shares
0
reactions
0
persons
11
keywords
15
excerpts

A document containing pharmaceutical development milestones and NDA (New Drug Application) details for various medical products, including treatments for prostate cancer, hot flashes, and other urological conditions. The document lists projected development timelines for different pharmaceutical products from 2018 to 2020.

👤 Named in This Document
No named persons linked yet

📋 Key Excerpts15

PersonKeyword
Excerpt 1
EFTA00810574 Veru projected development milestones veru PRODUCT INDICATION 2018 2019 2020 PROSTATE CANCER NOVEL MEDICINES Zuclomiphene Hot flashes caused by **NDA**
Excerpt 2
hormone therapy VERU-111 (bisindole) Metastatic prostate IND P1b/P2 P3 capsules cancer UROLOGY SPECIALTY PHARMACEUTICALS Tamsulosin XR BPH without food BE3 **NDA**
Excerpt 3
Post approval afely study granules & capsules effect US launch Tadalafil-finasteride BPH and erectile BE **NDA** US launch combo tablets dysfunction Solifenacin

Discussion

Let the world know how you feel.

What you just read should make you angry. Channel that into 17 syllables. Our AI helps you craft a haiku in seconds — then share it with the world.

Power hides in dark But sunlight finds every crack Truth cannot be bought

— Sarah K., after reading this document
✍️ Write Your Haiku

Haikus for Humanity — 5 · 7 · 5

React
Share𝕏🦋FBinFund Accountability